Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report

Overview of attention for article published in Frontiers in oncology, March 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 19,960 followers.

RT @FrontOncology: New research: Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma…

14 Mar 2024

Reply Repost Favourite

RT @FrontOncology: New research: Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma…

14 Mar 2024

Reply Repost Favourite

New research: Tislelizumab induced dual organs dysfunction in a patient with advanced esophageal squamous cell carcinoma: a case report: Background Tislelizumab, a humanized IgG4 anti-PD-1 monoclonal antibody has been approved in China and… https://t.co/P

14 Mar 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.